TomoTherapy shareholders have approved the sale of their Madison company to Accuray, of Sunnyvale, Calif., for $277 million in cash and stock. Established in 1997 based on technology with UW-Madison roots, TomoTherapy?s Hi-Art system spirals around a patient firing radiation beams at cancerous tissue.
Office of Strategic Communication